4.6 Article

Entry and Release of Hepatitis C Virus in Polarized Human Hepatocytes

Journal

JOURNAL OF VIROLOGY
Volume 91, Issue 18, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.00478-17

Keywords

cell polarity; hepatitis C virus; virus egress; virus entry

Categories

Funding

  1. Marie Curie International Reintegration [PIRG-GA-2009-256300]
  2. French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
  3. ANR through ERA-NET Infect-ERA [ANR-13-IFEC-0002-01]
  4. Agence Nationale de la Recherche (ANR) [ANR-13-IFEC-0002] Funding Source: Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

Hepatitis C virus (HCV) primarily infects hepatocytes, which are highly polarized cells. The relevance of cell polarity in the HCV life cycle has been addressed only in distantly related models and remains poorly understood. Although polarized epithelial cells have a rather simple morphology with a basolateral and an apical domain, hepatocytes exhibit complex polarization structures. However, it has been reported that some selected polarized HepG2 cell clones can exhibit a honeycomb pattern of distribution of the tight-junction proteins typical of columnar polarized epithelia, which can be used as a simple model to study the role of cell polarization in viral infection of hepatocytes. To obtain similar clones, HepG2 cells expressing CD81 (HepG2-CD81) were used, and clones were isolated by limiting dilutions. Two clones exhibiting a simple columnar polarization capacity when grown on a semipermeable support were isolated and characterized. To test the polarity of HCV entry and release, our polarized HepG2-CD81 clones were infected with cell culture-derived HCV. Our data indicate that HCV binds equally to both sides of the cells, but productive infection occurs mainly when the virus is added at the basolateral domain. Furthermore, we also observed that HCV virions are released from the basolateral domain of the cells. Finally, when polarized cells were treated with oleic acid and U0126, a MEK inhibitor, to promote lipoprotein secretion, a higher proportion of infectious viral particles of lower density were secreted. This cell culture system provides an excellent model to investigate the influence of cell polarization on the HCV life cycle. IMPORTANCE Hepatitis C is a major health burden, with approximately 170 million persons infected worldwide. Hepatitis C virus (HCV) primarily infects hepatocytes, which are highly polarized cells with a complex organization. The relevance of cell polarity in the HCV life cycle has been addressed in distantly related models and remains unclear. Hepatocyte organization is complex, with multiple apical and basolateral surfaces. A simple culture model of HepG2 cells expressing CD81 that are able to polarize with unique apical and basolateral domains was developed to study HCV infection. With this model, we demonstrated that HCV enters and exits hepatocytes by the basolateral domain. Furthermore, lower-density viral particles were produced under conditions that promote lipoprotein secretion. This cell culture system provides a useful model to study the influence of cell polarization on HCV infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Microbiology

A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses

Thomas Meunier, Lowiese Desmarets, Simon Bordage, Moussa Bamba, Kevin Hervouet, Yves Rouille, Nathan Francois, Marion Decossas, Valentin Sencio, Francois Trottein, Fezan Honora Tra Bi, Olivier Lambert, Jean Dubuisson, Sandrine Belouzard, Sevser Sahpaz, Karin Seron

Summary: The study identified pheophorbide a (Pba) as a highly active antiviral molecule against SARS-CoV-2, MERS-CoV, and other enveloped viruses. Pba inhibits virus entry by directly targeting the viral particle and stiffening the viral membrane. The antiviral activity of Pba is dependent on light exposure. This natural antiviral compound holds potential for COVID-19 therapy and disinfection of SARS-CoV-2-contaminated surfaces.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Virology

GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition

Eloine Bestion, Keivan Zandi, Sandrine Belouzard, Julien Andreani, Hubert Lepidi, Marie Novello, Clara Rouquairol, Jean-Pierre Baudoin, Madani Rachid, Bernard La Scola, Jean-Louis Mege, Jean Dubuisson, Raymond F. Schinazi, Soraya Mezouar, Philippe Halfon

Summary: Since December 2019, the rapid spread of SARS-CoV-2 worldwide has caused over 280 million confirmed cases and 5 million deaths. Researchers have found that coronaviruses can hijack the autophagic process to facilitate viral replication. GNS561, a late-stage autophagy inhibitor, has shown antiviral activity against SARS-CoV-2 with a range of 6-40 nM, making it the most powerful molecule investigated for SARS-CoV-2 infection. GNS561 disrupts the autophagy mechanism and reduces SARS-CoV-2 virions in a mouse model.

VIRUSES-BASEL (2022)

Article Pharmacology & Pharmacy

Anti-HCV Tannins From Plants Traditionally Used in West Africa and Extracted With Green Solvents

Moussa Bamba, Simon Bordage, Marie-Emmanuelle Sahuc, Sophie Moureu, Jennifer Samaillie, Vincent Roumy, Peggy Vauchel, Krasimir Dimitrov, Yves Rouille, Jean Dubuisson, Fezan Honora Tra Bi, Karin Seron, Sevser Sahpaz

Summary: The Carapa procera DC. and Pericopsis laxiflora (Benth.ex Baker) Meeuwen species from Cote d'Ivoire were found to have high antiviral activity against HCV, with low toxicity for hepatic cells. The crude extracts from these plants were rich in polyphenols, including active tannins. Removing the tannins from the extracts resulted in a loss of anti-HCV activity. Using a hydro-ethanolic solvent instead of methanol produced tannin-rich extracts with similar antiviral activity.

FRONTIERS IN PHARMACOLOGY (2022)

Article Microbiology

Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice

Sandrine Belouzard, Arnaud Machelart, Valentin Sencio, Thibaut Vausselin, Eik Hoffmann, Nathalie Deboosere, Yves Rouille, Lowiese Desmarets, Karin Seron, Adeline Danneels, Cyril Robil, Loic Belloy, Camille Moreau, Catherine Piveteau, Alexandre Biela, Alexandre Vandeputte, Severine Heumel, Lucie Deruyter, Julie Dumont, Florence Leroux, Ilka Engelmann, Enagnon Kazali Alidjinou, Didier Hober, Priscille Brodin, Terence Beghyn, Francois Trottein, Benoit Deprez, Jean Dubuisson

Summary: In this study, the researchers screened a library of drug compounds to identify potential antivirals against SARS-CoV-2. They discovered that clofoctol, an antibacterial drug used for respiratory tract infections, exhibited significant antiviral activity and had favorable safety and pharmacokinetic properties. In vivo experiments showed that clofoctol reduced inflammatory gene expression and pulmonary pathology. These findings suggest that clofoctol could be a promising therapeutic candidate for the treatment of COVID-19 patients.

PLOS PATHOGENS (2022)

Article Cell Biology

SARS-CoV-2 infection induces persistent adipose tissue damage in aged golden Syrian hamsters

Gemma Bogard, Johanna Barthelemy, Aline Hantute-Ghesquier, Valentin Sencio, Patricia Brito-Rodrigues, Karin Seron, Cyril Robil, Anne Flourens, Florence Pinet, Delphine Eberle, Francois Trottein, Martine Duterque-Coquillaud, Isabelle Wolowczuk

Summary: COVID-19 primarily affects the respiratory system, but it also has extrapulmonary manifestations. It has been found that SARS-CoV-2 can directly affect white adipose tissue (WAT), leading to insulin resistance and dyslipidemia. However, there is limited data on the impact of SARS-CoV-2 on WAT in older individuals. This study revealed that SARS-CoV-2 infection caused changes in adipocyte size and lipid metabolism in WAT, and older hamsters had a more severe response. Additionally, older hamsters showed difficulties in clearing dead adipocytes by macrophages, leading to the persistence of large adipose crown-like structures (CLSs).

CELL DEATH & DISEASE (2023)

Article Chemistry, Medicinal

Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses

Lucile Brier, Haitham Hassan, Xavier Hanoulle, Valerie Landry, Danai Moschidi, Lowiese Desmarets, Yves Rouille, Julie Dumont, Adrien Herledan, Sandrine Warenghem, Catherine Piveteau, Paul Carr, Sarah Ikherbane, Francois-Xavier Cantrelle, Elian Dupre, Jean Dubuisson, Sandrine Belouzard, Florence Leroux, Benoit Deprez, Julie Charton

Summary: Since the end of 2019, the global outbreak of the coronavirus SARS-CoV-2 has caused a significant increase in infections and deaths worldwide. Researchers have identified two proteases, 3CLpro and papain-like protease, encoded by the virus that play a crucial role in the virus lifecycle. Targeting the 3CLpro, which is highly conserved within this viral family, a screening of over 89,000 small molecules led to the discovery of a potent inhibitor of the SARS-CoV-2 3CLpro. The mechanism of inhibition, interaction with the protease, specificity against host proteases, and promising antiviral properties in cells are reported.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

New Phenolic Lipids from the Leaves of Clausena harmandiana Inhibit SARS-CoV-2 Entry into Host Cells

Marion Chambon, Charline Herrscher, Dana Al Halabi, Nathan Francois, Sandrine Belouzard, Stephanie Boutet, Van Cuong Pham, Thi Mai Huong Doan, Karin Seron, Patrick Mavingui, Marc Litaudon, Chaker El Kalamouni, Cecile Apel

Summary: The COVID-19 pandemic has highlighted the need for antivirals against coronaviruses. A study found that an ethyl acetate extract from the leaves of Clausena harmandiana showed significant activity against SARS-CoV-2, with two phenolic lipids inhibiting the virus. This suggests that phenolic lipids from Clausena harmandiana could be a potential source of new antiviral agents against coronaviruses.

MOLECULES (2023)

Article Virology

Lichen or Associated Micro-Organism Compounds Are Active against Human Coronaviruses

Lowiese Desmarets, Marion Millot, Marylene Chollet-Krugler, Joel Boustie, Charline Camuzet, Nathan Francois, Yves Rouille, Sandrine Belouzard, Sophie Tomasi, Lengo Mambu, Karin Seron

Summary: This study identifies four lichen compounds that exhibit antiviral activity against human coronaviruses, including SARS-CoV-2. One of these compounds, perlatolic acid, shows promising antiviral activity against SARS-CoV-2.

VIRUSES-BASEL (2023)

Article Plant Sciences

Eremoxylarins D-J, Antibacterial Eremophilane Sesquiterpenes Discovered from an Endolichenic Strain of Xylaria hypoxylon

Alice Miral, Solenn Ferron, Isabelle Rouaud, Dinmukhammed Slyambayev, Latifa Bousarghin, Charline Camuzet, Sandrine Belouzard, Karin Seron, Pierre Le Pogam, Sylvain Tranchimand, Sophie Tomasi

Summary: An endolichenic strain of Xylaria hypoxylon cultivated alone or in coculture with Dendrothyrium variisporum produced seven new bioactive eremophilane sesquiterpenes. Eremoxylarin I exhibited selective activity against methicillin-resistant Staphylococcus aureus and HCoV-229E.

JOURNAL OF NATURAL PRODUCTS (2023)

Article Biochemistry & Molecular Biology

The KxGxYR and DxE motifs in the C-tail of the Middle East respiratory syndrome coronavirus membrane protein are crucial for infectious virus assembly

Lowiese Desmarets, Adeline Danneels, Julien Burlaud-Gaillard, Emmanuelle Blanchard, Jean Dubuisson, Sandrine Belouzard

Summary: The membrane protein of Middle East respiratory syndrome coronavirus (MERS-CoV) plays a crucial role in the virus assembly process. Proper intracellular trafficking and subcellular localization of the M protein are essential for virus formation.

CELLULAR AND MOLECULAR LIFE SCIENCES (2023)

No Data Available